The structural biology and molecular modeling techniques market size has grown rapidly in recent years. It will grow from $10.28 billion in 2025 to $12.19 billion in 2026 at a compound annual growth rate (CAGR) of 18.5%. The growth in the historic period can be attributed to increasing pharmaceutical research activities, expansion of academic structural biology programs, availability of protein structure databases, growth of computational chemistry tools, rising investments in drug discovery research.
The structural biology and molecular modeling techniques market size is expected to see rapid growth in the next few years. It will grow to $23.53 billion in 2030 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to increasing demand for accelerated drug development, rising adoption of cloud and saas modeling tools, expansion of precision medicine research, growing integration of ai in life sciences, increasing use of virtual screening platforms. Major trends in the forecast period include increasing adoption of ai-driven molecular modeling tools, rising use of cloud-based structural biology platforms, growing integration of simulation and docking software, expansion of data-driven drug discovery applications, enhanced focus on structure-based drug design.
The growing adoption of personalized medicine is anticipated to accelerate the expansion of the structural biology and molecular modeling techniques market in the coming years. Personalized medicine represents an advanced healthcare approach that customizes medical treatments and interventions based on the unique characteristics of individual patients. Structural biology and molecular modeling techniques are integral to this approach, as they facilitate the identification and validation of molecular targets, support drug discovery and development, enable the interpretation of genetic variations, predict drug-target interactions, optimize drug delivery strategies, and aid in biomarker discovery. For example, in February 2024, according to the Personalized Medicine Coalition (PMC), a United States-based nonprofit research organization, the United States Food and Drug Administration approved 16 new personalized therapies for patients with rare diseases in 2023, compared with six approvals in 2022. The 2023 approvals also included seven oncology therapies and three treatments addressing other medical conditions. As a result, the rising adoption of personalized medicine is contributing to the growth of the structural biology and molecular modeling techniques market.
Major players in the structural biology and molecular modeling techniques market are developing new models, such as AI cloud services, to secure a competitive advantage. AI cloud services encompass the provision of artificial intelligence capabilities and tools through cloud computing platforms, allowing businesses and developers to access, deploy, and scale AI applications without requiring extensive on-premises infrastructure. For instance, in March 2023, Nvidia Corporation, a US-based software company, launched a suite of generative AI cloud services known as the BioNeMo Cloud offering, part of NVIDIA AI Foundations. This service accelerates life sciences research, drug discovery, and protein engineering by providing pretrained AI models and enabling researchers to customize them using proprietary data. The offering includes six new optimized, open-source models, such as AlphaFold2 for protein structure determination and MoFlow for molecular optimization and small molecule generation.
In August 2023, Optibrium, a United Kingdom-based developer of software and artificial intelligence solutions for drug discovery, acquired BioPharmics LLC for an undisclosed consideration. This acquisition is intended to strengthen Optibrium’s three-dimensional drug design and visualization capabilities by incorporating advanced ligand- and structure-based modeling functionalities into its StarDrop platform, which is used for small-molecule design, optimization, and data analysis. BioPharmics LLC is a United States-based computational drug design company known for its advanced algorithms and software solutions for three-dimensional ligand conversion, conformer generation, molecular docking, molecular similarity analysis, and binding affinity prediction.
Major companies operating in the structural biology and molecular modeling techniques market are Agile Molecule Inc., Dassault Systèmes SE, Chemical Computing Group ULC, Biomax Informatics AG, Acellera Ltd., Schrödinger Inc., OpenEye Scientific Software Inc., BioSolveIT GmbH, Optibrium Ltd., Simulations Plus Inc., Certara L.P., Genedata AG, Inte:Ligand GmbH, Molecular Networks GmbH, Molecular Discovery Ltd., Cresset Group Ltd., Biovista Inc., Collaborative Drug Discovery Inc., Dotmatics Ltd., Insilico Biotechnology AG, Leadscope Inc.
North America was the largest region in the structural biology and molecular modelling techniques market in 2025. The regions covered in the structural biology and molecular modeling techniques market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the structural biology and molecular modeling techniques market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the structural biology and molecular modeling techniques market by increasing costs of imported high-performance computing hardware, visualization workstations, specialized software licenses, and data storage infrastructure. Research institutions and pharmaceutical companies in North America and Europe are most affected due to dependence on imported computing equipment, while Asia-Pacific faces cost pressure on technology deployment. These tariffs are increasing research expenses and slowing infrastructure upgrades. However, they are also encouraging cloud-based solutions, regional software development, and localized research infrastructure investments.
The structural biology and molecular modeling techniques market research report is one of a series of new reports that provides structural biology and molecular modeling techniques market statistics, including structural biology and molecular modeling techniques industry global market size, regional shares, competitors with a structural biology and molecular modeling techniques market share, detailed structural biology and molecular modeling techniques market segments, market trends and opportunities, and any further data you may need to thrive in the structural biology and molecular modeling techniques industry. This structural biology and molecular modeling techniques market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Structural biology focuses on examining the three-dimensional structures of essential molecules and macromolecules within biological systems, such as sugars, proteins, and nucleic acids. Molecular modeling involves the creation, visualization, and modification of these three-dimensional structures of chemical and biological molecules, along with identifying physicochemical properties that can help interpret the structural activity relationship (SAR) of the biological molecules.
The primary tools employed in structural biology and molecular modeling encompass Software as a Service (SaaS) and standalone modeling software, visualization and analysis tools, databases, and other specialized utilities. SaaS operates through a cloud-based framework, hosted by a provider and accessible to end-users online, while standalone software requires installation and maintenance on the user's computer, necessitating the user's management of the program and hardware, unless covered by provided software maintenance and support. SaaS and standalone modeling tools serve specific functions within predefined parameters. These techniques find extensive application in various domains such as drug development, drug discovery, and other pharmaceutical, biotechnological, academic, and clinical trial endeavors.
The structural biology and molecular modeling techniques market includes revenues earned by entities by using techniques such as homology modeling, threading, molecular dynamics cryo-electron microscopy (cryo-EM), nuclear magnetic resonance spectroscopy of proteins (NMR), and electron paramagnetic resonance (EPR). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The structural biology and molecular modeling techniques market size is expected to see rapid growth in the next few years. It will grow to $23.53 billion in 2030 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to increasing demand for accelerated drug development, rising adoption of cloud and saas modeling tools, expansion of precision medicine research, growing integration of ai in life sciences, increasing use of virtual screening platforms. Major trends in the forecast period include increasing adoption of ai-driven molecular modeling tools, rising use of cloud-based structural biology platforms, growing integration of simulation and docking software, expansion of data-driven drug discovery applications, enhanced focus on structure-based drug design.
The growing adoption of personalized medicine is anticipated to accelerate the expansion of the structural biology and molecular modeling techniques market in the coming years. Personalized medicine represents an advanced healthcare approach that customizes medical treatments and interventions based on the unique characteristics of individual patients. Structural biology and molecular modeling techniques are integral to this approach, as they facilitate the identification and validation of molecular targets, support drug discovery and development, enable the interpretation of genetic variations, predict drug-target interactions, optimize drug delivery strategies, and aid in biomarker discovery. For example, in February 2024, according to the Personalized Medicine Coalition (PMC), a United States-based nonprofit research organization, the United States Food and Drug Administration approved 16 new personalized therapies for patients with rare diseases in 2023, compared with six approvals in 2022. The 2023 approvals also included seven oncology therapies and three treatments addressing other medical conditions. As a result, the rising adoption of personalized medicine is contributing to the growth of the structural biology and molecular modeling techniques market.
Major players in the structural biology and molecular modeling techniques market are developing new models, such as AI cloud services, to secure a competitive advantage. AI cloud services encompass the provision of artificial intelligence capabilities and tools through cloud computing platforms, allowing businesses and developers to access, deploy, and scale AI applications without requiring extensive on-premises infrastructure. For instance, in March 2023, Nvidia Corporation, a US-based software company, launched a suite of generative AI cloud services known as the BioNeMo Cloud offering, part of NVIDIA AI Foundations. This service accelerates life sciences research, drug discovery, and protein engineering by providing pretrained AI models and enabling researchers to customize them using proprietary data. The offering includes six new optimized, open-source models, such as AlphaFold2 for protein structure determination and MoFlow for molecular optimization and small molecule generation.
In August 2023, Optibrium, a United Kingdom-based developer of software and artificial intelligence solutions for drug discovery, acquired BioPharmics LLC for an undisclosed consideration. This acquisition is intended to strengthen Optibrium’s three-dimensional drug design and visualization capabilities by incorporating advanced ligand- and structure-based modeling functionalities into its StarDrop platform, which is used for small-molecule design, optimization, and data analysis. BioPharmics LLC is a United States-based computational drug design company known for its advanced algorithms and software solutions for three-dimensional ligand conversion, conformer generation, molecular docking, molecular similarity analysis, and binding affinity prediction.
Major companies operating in the structural biology and molecular modeling techniques market are Agile Molecule Inc., Dassault Systèmes SE, Chemical Computing Group ULC, Biomax Informatics AG, Acellera Ltd., Schrödinger Inc., OpenEye Scientific Software Inc., BioSolveIT GmbH, Optibrium Ltd., Simulations Plus Inc., Certara L.P., Genedata AG, Inte:Ligand GmbH, Molecular Networks GmbH, Molecular Discovery Ltd., Cresset Group Ltd., Biovista Inc., Collaborative Drug Discovery Inc., Dotmatics Ltd., Insilico Biotechnology AG, Leadscope Inc.
North America was the largest region in the structural biology and molecular modelling techniques market in 2025. The regions covered in the structural biology and molecular modeling techniques market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the structural biology and molecular modeling techniques market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the structural biology and molecular modeling techniques market by increasing costs of imported high-performance computing hardware, visualization workstations, specialized software licenses, and data storage infrastructure. Research institutions and pharmaceutical companies in North America and Europe are most affected due to dependence on imported computing equipment, while Asia-Pacific faces cost pressure on technology deployment. These tariffs are increasing research expenses and slowing infrastructure upgrades. However, they are also encouraging cloud-based solutions, regional software development, and localized research infrastructure investments.
The structural biology and molecular modeling techniques market research report is one of a series of new reports that provides structural biology and molecular modeling techniques market statistics, including structural biology and molecular modeling techniques industry global market size, regional shares, competitors with a structural biology and molecular modeling techniques market share, detailed structural biology and molecular modeling techniques market segments, market trends and opportunities, and any further data you may need to thrive in the structural biology and molecular modeling techniques industry. This structural biology and molecular modeling techniques market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Structural biology focuses on examining the three-dimensional structures of essential molecules and macromolecules within biological systems, such as sugars, proteins, and nucleic acids. Molecular modeling involves the creation, visualization, and modification of these three-dimensional structures of chemical and biological molecules, along with identifying physicochemical properties that can help interpret the structural activity relationship (SAR) of the biological molecules.
The primary tools employed in structural biology and molecular modeling encompass Software as a Service (SaaS) and standalone modeling software, visualization and analysis tools, databases, and other specialized utilities. SaaS operates through a cloud-based framework, hosted by a provider and accessible to end-users online, while standalone software requires installation and maintenance on the user's computer, necessitating the user's management of the program and hardware, unless covered by provided software maintenance and support. SaaS and standalone modeling tools serve specific functions within predefined parameters. These techniques find extensive application in various domains such as drug development, drug discovery, and other pharmaceutical, biotechnological, academic, and clinical trial endeavors.
The structural biology and molecular modeling techniques market includes revenues earned by entities by using techniques such as homology modeling, threading, molecular dynamics cryo-electron microscopy (cryo-EM), nuclear magnetic resonance spectroscopy of proteins (NMR), and electron paramagnetic resonance (EPR). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Structural Biology and Molecular Modeling Techniques Market Characteristics
3. Structural Biology and Molecular Modeling Techniques Market Supply Chain Analysis
4. Global Structural Biology and Molecular Modeling Techniques Market Trends and Strategies
5. Structural Biology and Molecular Modeling Techniques Market Analysis of End Use Industries
7. Global Structural Biology and Molecular Modeling Techniques Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Structural Biology and Molecular Modeling Techniques Total Addressable Market (TAM) Analysis for the Market
9. Structural Biology and Molecular Modeling Techniques Market Segmentation
10. Structural Biology and Molecular Modeling Techniques Market Regional and Country Analysis
11. Asia-Pacific Structural Biology and Molecular Modeling Techniques Market
12. China Structural Biology and Molecular Modeling Techniques Market
13. India Structural Biology and Molecular Modeling Techniques Market
14. Japan Structural Biology and Molecular Modeling Techniques Market
15. Australia Structural Biology and Molecular Modeling Techniques Market
16. Indonesia Structural Biology and Molecular Modeling Techniques Market
17. South Korea Structural Biology and Molecular Modeling Techniques Market
18. Taiwan Structural Biology and Molecular Modeling Techniques Market
19. South East Asia Structural Biology and Molecular Modeling Techniques Market
20. Western Europe Structural Biology and Molecular Modeling Techniques Market
21. UK Structural Biology and Molecular Modeling Techniques Market
22. Germany Structural Biology and Molecular Modeling Techniques Market
23. France Structural Biology and Molecular Modeling Techniques Market
24. Italy Structural Biology and Molecular Modeling Techniques Market
25. Spain Structural Biology and Molecular Modeling Techniques Market
26. Eastern Europe Structural Biology and Molecular Modeling Techniques Market
27. Russia Structural Biology and Molecular Modeling Techniques Market
28. North America Structural Biology and Molecular Modeling Techniques Market
29. USA Structural Biology and Molecular Modeling Techniques Market
30. Canada Structural Biology and Molecular Modeling Techniques Market
31. South America Structural Biology and Molecular Modeling Techniques Market
32. Brazil Structural Biology and Molecular Modeling Techniques Market
33. Middle East Structural Biology and Molecular Modeling Techniques Market
34. Africa Structural Biology and Molecular Modeling Techniques Market
36. Structural Biology and Molecular Modeling Techniques Market Competitive Landscape and Company Profiles
37. Structural Biology and Molecular Modeling Techniques Market Other Major and Innovative Companies
40. Structural Biology and Molecular Modeling Techniques Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Structural Biology And Molecular Modeling Techniques Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses structural biology and molecular modeling techniques market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for structural biology and molecular modeling techniques? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The structural biology and molecular modeling techniques market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Tools: SaaS And Standalone Modeling; Visualization And Analysis; Databases; Other Tools2) By Application: Drug Development; Drug Discovery; Other Applications
3) By End-Users: Pharmaceutical; Biotechnological; Academic
Subsegments:
1) By SaaS And Standalone Modeling: Cloud-Based Modeling Tools; Desktop Modeling Software2) By Visualization And Analysis: Molecular Visualization Software; Structural Analysis Tools
3) By Databases: Protein Structure Databases; Molecular Interaction Databases
4) By Other Tools: Simulation Software; Docking Software; Other Analytical Tools
Companies Mentioned: Agile Molecule Inc.; Dassault Systèmes SE; Chemical Computing Group ULC; Biomax Informatics AG; Acellera Ltd.; Schrödinger Inc.; OpenEye Scientific Software Inc.; BioSolveIT GmbH; Optibrium Ltd.; Simulations Plus Inc.; Certara L.P.; Genedata AG; Inte:Ligand GmbH; Molecular Networks GmbH; Molecular Discovery Ltd.; Cresset Group Ltd.; Biovista Inc.; Collaborative Drug Discovery Inc.; Dotmatics Ltd.; Insilico Biotechnology AG; Leadscope Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Structural Biology and Molecular Modeling Techniques market report include:- Agile Molecule Inc.
- Dassault Systèmes SE
- Chemical Computing Group ULC
- Biomax Informatics AG
- Acellera Ltd.
- Schrödinger Inc.
- OpenEye Scientific Software Inc.
- BioSolveIT GmbH
- Optibrium Ltd.
- Simulations Plus Inc.
- Certara L.P.
- Genedata AG
- Inte:Ligand GmbH
- Molecular Networks GmbH
- Molecular Discovery Ltd.
- Cresset Group Ltd.
- Biovista Inc.
- Collaborative Drug Discovery Inc.
- Dotmatics Ltd.
- Insilico Biotechnology AG
- Leadscope Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 12.19 Billion |
| Forecasted Market Value ( USD | $ 23.53 Billion |
| Compound Annual Growth Rate | 17.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
